Low dose streptozotocin-induced diabetes in rat insulin promoter-mCD80-transgenic mice is T cell autoantigen-specific and CD28 dependent

Journal of Immunology

Volumn 166, Issue 4, 2001, Pages 2531-2539

  Pechhold, K ^a   Patterson, N B ^a   Blum, C ^a   Fleischacker, C L ^a   Boehm, B O ^a   Harlan, D M ^a  

^a ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; INSULIN;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; TRANSGENIC MOUSE;

EID: 0035865053     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.4.2531     Document Type: Article

References (57)

1. Signals and signs for lymphocyte responses
2. The role of the CD28 receptor during T-cell responses to antigen
3. Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations
4. Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7
5. Comparative analysis of B7-1 and B7-2 costimulatory ligands: Expression and function
6. + T cells
7. The inflammatory cytokines IFN-γ plus TNF-α induce regulated expression of CD80 (B7-1) but not CD86 (B7-2) on murine fibroblasts
8. Primary porcine endothelial cells express membranebound B7-2 (CD86) and a soluble factor that costimulate cyclosporin A-resistant and CD28-dependent human T cell proliferation
9. B7/BB-1 expression and hepatitis activity in liver tissues of patients with chronic hepatitis C
10. Mice expressing both B7-1 and viral glycoprotein on pancreatic β-cells along with glycoprotein-specific transgenic T-cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness
11. Very-low-dose streptozotocin induces diabetes in insulin promoter-mB7-1 transgenic mice
12. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice
13. Expression of α tumor necrosis factor a transgene in murine pancreatic β cells results in severe and permanent insulitis without evolution towards diabetes
14. + T-lymphocyte-independent autoimmune diabetes of early onset in transgenic mice
15. Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor α leads to autoimmunity in transgenic mice
16. The role of the T cell co-stimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen
17. Coexpression of B7-1 and viral ("self") transgenes in pancreatic β cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes
18. Expression of the co-stimulator molecule B7-1 in pancreatic β-cells accelerates diabetes in the NOD mouse
19. Differential T cell costimulatory requirements in CD28-deficient mice
20. Self antigens expressed by solid tumors do not efficiently stimulate naive or activated T cells: Implications for immunotherapy
21. Protection against lethal toxic shock by targeted disruption of the CD28 gene
22. Genetic influence of the streptozotocin-induced insulitis and hyperglycemia
23. T cell priming versus T cell tolerance induced by synthetic peptides
24. Measurement of rat insulin: Enzyme-linked immunosorbent assay with increased sensitivity, high accuracy, and greater practicability than established radioimmunoassay
25. An improved method for isolation of mouse pancreatic islets
26. Optimal lymphocytic choriomeningitis virus sequences restricted by H-2Db major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes
27. Identification of an autologous insulin B chain peptide as a target antigen for H-2Kb-restricted cytotoxic T lymphocytes
28. β cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin diabetic C57BL/6 mice
29. Transgenic mice expressing IFN-γ in pancreatic β-cells are resistant to streptozotocin-induced diabetes
30. Sex differences in the multiple-dose streptozotocin model of diabetes
31. Autoimmune insulitis and diabetes in the absence of antigen-specific contact between T cells and islet β-cells
32. The generation of memory antigen-specific cytotoxic T cell responses by CD28/CD80 interactions in the absence of antigen
33. Single cell analyses of cytokine production
34. Studies of streptozotocin-induced insulitis and diabetes
35. Streptozotocin-induced pancreatic insulitis: New model of diabetes mellitus
36. Immunologic studies on the induction of diabetes in experimental animals: Cellular basis for the induction of diabetes by streptozotocin
37. Genetic control of low-dose streptozotocin-induced autoimmune diabetes in mice
38. Streptozotocin: Its excretion and metabolism in the rat
39. Absence of B7-dependent responses in CD28-deficient mice
40. CD28/B7 costimulation regulates autoimmune diabetes induced with multiple low doses of streptozotocin
41. Skin allograft rejection in CD28-deficient mice
42. CD28 is not required for rejection of unmanipulated syngeneic and autologous tumors
43. CD28-deficient mice generate an impaired Th2 response to Schistosoma mansoni infection
44. Cellular interaction in germinal centers: Roles of CD40 ligand and B7-2 in established germinal centers
45. CD28 is required for germinal center formation
46. CD28 costimulation is crucial for the development of spontaneous autoimmune encephalomyelitis
47. CD28-deficient mice are highly resistant to collagen-induced arthritis
48. CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes
49. + islet-specific T cell clone
50. Diabetogenic T-cell clones
51. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells
52. Constitutive class I-restricted exogenous presentation of self antigens in vivo
53. The immune response to islets in experimental diabetes and insulin-dependent diabetes mellitus
54. Cytotoxic T lymphocyte activation by cross-priming
55. Uncovering subdominant cytotoxic T-lymphocyte responses in lymphocytic choriomeningitis virus-infected BALB/c mice
56. + T cell epitopes, virus load, and kinetics of primary antiviral CTL response
57. Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33